Mark Woodward

About Professor Mark Woodward

Senior Professorial Fellow, Professorial Unit

  • Chair of Statistics, Epidemiology and Women’s Health at Imperial College London
  • Professor of Medical Statistics, Faculty of Medicine, UNSW Sydney
  • PhD ,
  • FMedSci,
  • FAHMS,
  • FESC

Mark Woodward is Chair of Statistics, Epidemiology and Women’s Health at Imperial College London, Professor of Medical Statistics at the University of New South Wales, Senior Visiting Research Fellow of Green Templeton College, Oxford University and Honorary Professor at the universities of Dundee, Mahidol (Thailand) and the West Indies.

Mark is the author of over 850 peer-reviewed publications, 20 of which have over 1000 citations, and two text-books on statistical methods in medical research. He has been named amongst the world’s most citied researchers in each year since the current ranking system started in 2014, with a H-index of over 160.

Mark has undertaken 24 development aid missions in Africa and Asia and served on the governing councils of both the Institute of Statisticians and the Royal Statistical Society (RSS). His previous professorships have been at the University of Oxford, New York University, the University of Sydney, and as an adjunct professor at Johns Hopkins University.

Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

Cerebral Circulation - Cognition and Behavior Date published:

Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity

Journal of Environmental Sciences Date published:

Heavy metals are liver fibrosis risk factors in people without traditional liver disease etiologies

Journal of Environmental Sciences Date published:

A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis

Kidney International Date published:

Related Readings